NCT00419666View on ClinicalTrials.gov

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 1, 2006

Primary Completion Date

September 24, 2009

Study Completion Date

September 24, 2009

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

Calcitriol 3mcg/g

Calcitriol 3mcg/g ointment applied twice daily for 56 weeks.

Trial Locations (7)

55121

Dermatology Center For Children & Young Adults, Eagan

72205

Dermatology Research of Arkansas, Little Rock

77030

University of Texas-Houston Medical Center Dept of Dermatology, Houston

77598

Center for Clinical Studies, Webster

92123

Children's Hospital, Department of Pediatric and Adolescent Dermatology, San Diego

A1B 3E1

Nexus Clinical Research, St. John's

A1C 2H5

Newlab Clinical Research, Inc., St. John's

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00419666 - A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis | Biotech Hunter | Biotech Hunter